154 related articles for article (PubMed ID: 35900852)
21. Natural and synthetic retinoid X receptor ligands and their role in selected nuclear receptor action.
Brtko J; Dvorak Z
Biochimie; 2020 Dec; 179():157-168. PubMed ID: 33011201
[TBL] [Abstract][Full Text] [Related]
22. Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.
Sharma S; Shen T; Chitranshi N; Gupta V; Basavarajappa D; Sarkar S; Mirzaei M; You Y; Krezel W; Graham SL; Gupta V
Mol Neurobiol; 2022 Apr; 59(4):2027-2050. PubMed ID: 35015251
[TBL] [Abstract][Full Text] [Related]
23. 9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice.
Rühl R; Krzyżosiak A; Niewiadomska-Cimicka A; Rochel N; Szeles L; Vaz B; Wietrzych-Schindler M; Álvarez S; Szklenar M; Nagy L; de Lera AR; Krężel W
PLoS Genet; 2015 Jun; 11(6):e1005213. PubMed ID: 26030625
[TBL] [Abstract][Full Text] [Related]
24. Role of retinoids, rexinoids and thyroid hormone in the expression of cytochrome p450 enzymes.
Brtko J; Dvorak Z
Curr Drug Metab; 2011 Feb; 12(2):71-88. PubMed ID: 21401514
[TBL] [Abstract][Full Text] [Related]
25. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
26. Selective allosteric ligand activation of the retinoid X receptor heterodimers of NGFI-B and Nurr1.
Morita K; Kawana K; Sodeyama M; Shimomura I; Kagechika H; Makishima M
Biochem Pharmacol; 2005 Dec; 71(1-2):98-107. PubMed ID: 16288995
[TBL] [Abstract][Full Text] [Related]
27. RXRs: collegial partners.
Gilardi F; Desvergne B
Subcell Biochem; 2014; 70():75-102. PubMed ID: 24962882
[TBL] [Abstract][Full Text] [Related]
28. Advances in drug design with RXR modulators.
Vaz B; de Lera ÁR
Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
[TBL] [Abstract][Full Text] [Related]
29. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
[TBL] [Abstract][Full Text] [Related]
30. An Endogenous Mammalian Retinoid X Receptor Ligand, At Last!
de Lera ÁR; Krezel W; Rühl R
ChemMedChem; 2016 May; 11(10):1027-37. PubMed ID: 27151148
[TBL] [Abstract][Full Text] [Related]
31. The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation.
Qi JS; Desai-Yajnik V; Greene ME; Raaka BM; Samuels HH
Mol Cell Biol; 1995 Mar; 15(3):1817-25. PubMed ID: 7862171
[TBL] [Abstract][Full Text] [Related]
32. The multi-faceted role of retinoid X receptor in cardiovascular diseases.
Shao M; Lu L; Wang Q; Ma L; Tian X; Li C; Li C; Guo D; Wang Q; Wang W; Wang Y
Biomed Pharmacother; 2021 May; 137():111264. PubMed ID: 33761589
[TBL] [Abstract][Full Text] [Related]
33. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
Jurutka PW; Wagner CE
Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
[TBL] [Abstract][Full Text] [Related]
34. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
35. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.
Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH
J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536
[TBL] [Abstract][Full Text] [Related]
36. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
[TBL] [Abstract][Full Text] [Related]
37. Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.
Dawson MI; Ye M; Cao X; Farhana L; Hu QY; Zhao Y; Xu LP; Kiselyuk A; Correa RG; Yang L; Hou T; Reed JC; Itkin-Ansari P; Levine F; Sanner MF; Fontana JA; Zhang XK
ChemMedChem; 2009 Jul; 4(7):1106-19. PubMed ID: 19378296
[TBL] [Abstract][Full Text] [Related]
38. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
39. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
Crowe DL; Chandraratna RA
Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
[TBL] [Abstract][Full Text] [Related]
40. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
